DNB Asset Management AS lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 6.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 31,937 shares of the company’s stock after selling 2,023 shares during the period. DNB Asset Management AS’s holdings in HCA Healthcare were worth $14,910,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the company. Capital World Investors grew its position in shares of HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after purchasing an additional 179,443 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock valued at $880,199,000 after purchasing an additional 36,414 shares in the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Legal & General Group Plc grew its position in shares of HCA Healthcare by 0.8% during the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock valued at $479,267,000 after purchasing an additional 8,478 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of HCA Healthcare by 1.1% during the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock valued at $469,216,000 after purchasing an additional 11,829 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Analyst Upgrades and Downgrades
HCA has been the subject of a number of analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a report on Friday, April 24th. Mizuho increased their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Truist Financial lowered their price target on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a report on Friday, March 27th. Finally, Sanford C. Bernstein lowered their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a report on Tuesday, April 28th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $517.82.
HCA Healthcare Price Performance
Shares of NYSE HCA opened at $422.68 on Monday. The company has a market cap of $93.77 billion, a P/E ratio of 14.54, a PEG ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The firm has a 50-day simple moving average of $478.74 and a two-hundred day simple moving average of $485.96.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.
Insider Activity at HCA Healthcare
In other news, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.50% of the company’s stock.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
